Rachel Golonka
Discovering the role of gut microbiota and metabolites in liver cancer
Rachel Golonka is a PhD student at The University of Toledo, USA, investigating the role of gut microbiota in the pathogenesis of hepatocellular carcinoma (HCC). The gut microbiota is sensitive to genetic and environmental factors, which can cause them to switch from homeostatic eubiosis to pathological dysbiosis. However, it is unclear whether dysbiosis is an instigator or a bystander in HCC. To better understand this and determine whether gut microbiota dysbiosis has diagnostic potential for HCC, Rachel will use a mouse model and healthy and cancerous tissues to assess which intestinal bacteria could be pathogenic in HCC, which gut metabolites aggravate HCC, and how those microbial products could potentiate hepatocarcinogenesis.